Prior results do not guarantee a similar outcome.
Johnson & Johnson has recently recalled two hip implant devices manufactured by its subsidiary, DePuy Orthopaedics. The ASR XL Acetabular System and the ASR Hip Resurfacing System were both recalled this August.
The former is a metal hip socket used in traditional hip replacement; the latter is used in partial hip replacement, where half the joint is the patient’s bone, and the other half a metal resurfacing system. The ASR XL Acetabular System has been approved and implanted worldwide, and the ASR Hip Resurfacing System has only been approved and used outside the United States.
The main problem with the DePuy Orthopaedics implants is that the constant grinding of the metal joints can produce residue from wear, which can irritate a patient and cause the implant to fail. Many medical providers that have used the DePuy implants have noticed a higher failure rate among the DePuy implants compared to other similar implants manufactured by other companies.
In late August of this year, the FDA wrote a letter to DePuy Orthopaedics accusing the company of illegally marketing an unapproved knee device (the ASR Hip Resurfacing System) and selling an unapproved hip replacement (the ASR XL Acetabular System). The FDA has received complaints from consumers about these systems for two years. The hip replacement recall is the latest in a series of recalls by Johnson & Johnson, including Children’s Tylenol and Acuvue contact lenses.
Larkin Ingrassia, LLP has already filed suit on this issue in court. If you have concerns about your hip implant device or you have been injured by a hip implant, contact an experienced products liability attorney at Larkin Ingrassia, LLP for help.
Learn about details of a hip replacement devices recall by Johnson & Johnson subsidiary, DePuy Orthopaedics. This article is brought to you by Larkin Ingrassia, LLP.